Revolution Medicines, Inc. Warrant
- RVMDW
- NASDAQ
- Biotechnology
- Oncology (RAS-Mutant Cancers)
- Precision Cancer Therapies
- KRAS Inhibitors
$8.40
Today −13.98%Quote Oct 16, 2026, 07:59 PM UTC
−18.45%over the last month
Max drawdown −28.2%From 1-month high −28.2%3 months −2.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.80B
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$8.36
0.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RVMDWPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
883
Founded
2014